Results 201 to 210 of about 3,847,841 (356)

Managing and mitigating future public health risks: Planetary boundaries, global catastrophic risk, and inclusive wealth

Risk Analysis, EarlyView.
Abstract There are two separate conceptualizations for assessing existential risks: Planetary Boundaries (PBs) and global catastrophic risks (GCRs). While these concepts are similar in principle, their underpinning literatures tend not to engage with each other.
Eoin McLaughlin, Matthias Beck
wiley   +1 more source

Delayed lichenoid drug eruption associated with apremilast. [PDF]

JAAD Case Rep
Hinderks-Davis B, Hintz M, Green AL.
europepmc   +1 more source

Cholestatic Pruritus Mimicking a Cutaneous Drug Eruption. [PDF]

Cureus, 2023
Reddy AM, Najmi M, Parekh P.
europepmc   +1 more source

Successful desensitization of a fixed drug eruption caused by allopurinol☆☆☆★★★

, 1998
Ana Umpiérrez, Javier Cuesta‐Herranz, Manuel de las Heras, M Lluch‐Bernal, E. Figueredo, J. Sastre   +5 more
openalex   +1 more source

Drug Eruptions

International Journal of Clinical Practice, 1968
openaire   +2 more sources

Cosmovision as Cognitive Technology: The Case of Mesoamerican Medicinal Knowledge

Topics in Cognitive Science, EarlyView.
Abstract We examine the use of cognitive technologies in the acquisition and retention of botanical and medicinal knowledge. We focus on the Cruz‐Badianus codex, a 16th‐century Nahua (Aztec) herbarium which discusses the use of plants for a range of illnesses.
Johan De Smedt, Helen De Cruz
wiley   +1 more source

Fixed drug eruption induced by Etoricoxib in Thailand: A case report. [PDF]

Toxicol Rep
Siriwattanasatorn M, Kamudhamas A, Sivapornpan N, Noonpugdee M, Kamalashiran C, Phetkate P.   +5 more
europepmc   +1 more source

Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions

, 2000
Nikhil Yawalkar, M Shrikhande, Yvonne Hari, Helga Nievergelt, Lasse R. Braathen, Werner J. Pichler   +5 more
openalex   +1 more source

LICHENOID DRUG ERUPTION ASSOCIATED WITH IMATINIB MESYLATE: TWO CASES [PDF]

, 2007
İlhami Kıkı, Mustafa Atasoy, Nesrin Gürsan, Mehmet Ali Gündoğdu, Fuat Erdem, Şevki Özdemir   +5 more
openalex   +1 more source

Efficacy and field safety of ilunocitinib for the control of atopic dermatitis in client‐owned dogs: A multicentre, double‐masked, randomised, placebo‐controlled clinical trial

Veterinary Dermatology, EarlyView.
Background – Inhibition of the Janus kinase (JAK) pathway is a well‐established option for canine atopic dermatitis (cAD). Objective – To evaluate the efficacy and safety of ilunocitinib, a novel JAK inhibitor for the control of pruritus and skin lesions in client‐owned dogs with cAD.
Sophie Forster, Candace M. Trout, Simona Despa, Annette Boegel, Darren Berger, Stephen King   +5 more
wiley   +1 more source